Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples